Sleep Apnea
4
Pipeline Programs
4
Companies
5
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
3
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
ApnimedSivopixant
TakedaDanavorexton
EisaiZonisamide
ApnimedSAS0421a
ZollDual Channel Stimulation
Clinical Trials (5)
Total enrollment: 91 patients across 5 trials
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
Start: Apr 2025Est. completion: Dec 2025
Phase 2Recruiting
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
Start: May 2023Est. completion: Sep 202441 patients
Phase 2Terminated
Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients
Start: Mar 2010Est. completion: Jun 201350 patients
Phase 2Completed
Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea
Start: Jan 2019Est. completion: Jul 2021
Phase 1/2Completed
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 91 patients
4 companies competing in this space